Skip to main content
. Author manuscript; available in PMC: 2018 Feb 20.
Published in final edited form as: J Am Chem Soc. 2017 Oct 30;139(44):15628–15631. doi: 10.1021/jacs.7b09790

Figure 2.

Figure 2

Perfluoroarene-based macrocyclic TP10 analogues have increased uptake in endothelial cells. Flow cytometry analysis of hCMEC/D3 cells treated with 2.5 µM of each peptide for 2 h at 37 °C. The macrocyclic variants display up to a 12-fold increase in mean fluorescence intensity relative to native TP10 (n = 3).